Modified Oligonucleotides As Therapeutic and Diagnostic Agents
Overview
Affiliations
Modified oligonucleotides and their analogs represent an exciting new class of agents with potential therapeutic and diagnostic applications. Among the most extensively investigated analogs are oligonucleoside phosphorothioates, some of which incorporate 'hairpin' structures at the 3' end and 'chimeras' that bear two modified oligonucleotides, all potential therapeutic candidates. To further enhance their potential, bio-reversible analogs of oligonucleotides have been synthesized. Several isosteric analogs of phosphoric diester oligonucleotides with neutral achiral backbones, and other novel molecules, such as peptide nucleic acids and circular oligonucleotides, are also reported to form stable duplexes with complementary RNA/DNA and are currently under investigation. Additionally, oligonucleotides carrying a variety of fluorescent tags have been used as probes with potential for diagnostic applications.
Pipkorn R, Wiessler M, Waldeck W, Hennrich U, Nokihara K, Beining M Int J Med Sci. 2012; 9(1):1-10.
PMID: 22211082 PMC: 3222083. DOI: 10.7150/ijms.9.1.
Thermodynamics of RNA duplexes modified with unlocked nucleic acid nucleotides.
Pasternak A, Wengel J Nucleic Acids Res. 2010; 38(19):6697-706.
PMID: 20562222 PMC: 2965255. DOI: 10.1093/nar/gkq561.
Lorenz P, Misteli T, Baker B, Bennett C, Spector D Nucleic Acids Res. 1999; 28(2):582-92.
PMID: 10606658 PMC: 102511. DOI: 10.1093/nar/28.2.582.
Dynamics of phosphorothioate oligonucleotides in normal and laser photocoagulated retina.
Shen W, Garrett K, da Cruz L, Constable I, Rakoczy P Br J Ophthalmol. 1999; 83(7):852-61.
PMID: 10381674 PMC: 1723113. DOI: 10.1136/bjo.83.7.852.
Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.
Lorenz P, Baker B, Bennett C, Spector D Mol Biol Cell. 1998; 9(5):1007-23.
PMID: 9571236 PMC: 25326. DOI: 10.1091/mbc.9.5.1007.